Russell E. Lewis

发表

Classic Fishing Lures

Russell E. Lewis, 2005 .

Mitigating carbon dioxide corrosion in production vessels

Russell E. Lewis, David K. Barbin, 1994 .

Old Fishing Lures & Tackle: Identification and Value Guide

Russell E. Lewis, Carl F. Luckey, 1980 .

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Russell E. Lewis, Michael E. Ernst, Erika J. Ernst, 1998, Antimicrobial Agents and Chemotherapy.

Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology

Russell E. Lewis, Erika J. Ernst, Michael E. Klepser, 2000, Antimicrobial Agents and Chemotherapy.

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

Russell E. Lewis, J. Thornby, H. Kantarjian, 2003, Cancer.

Toward more effective antifungal therapy: the prospects of combination therapy

Russell E. Lewis, D. Kontoyiannis, R. Lewis, 2004, British journal of haematology.

Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: Difficulties in Establishing Correlation Between In Vitro Susceptibility Data and the Outcome of Initial Amphotericin B Therapy

Russell E. Lewis, D. Kontoyiannis, M. Lionakis, 2005, Pharmacotherapy.

Decision Making in Antifungal Monotherapy versus Combination Therapy

Russell E. Lewis, R. Lewis, 2006, Pharmacotherapy.

Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.

Russell E. Lewis, G. Halder, D. Kontoyiannis, 2006, The Journal of infectious diseases.

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Russell E. Lewis, Vincent H. Tam, V. Tam, 2005, Antimicrobial Agents and Chemotherapy.

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study

Russell E. Lewis, P. Tamboli, D. Kontoyiannis, 2013, Mycoses.

Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis

Russell E. Lewis, D. Kontoyiannis, Randall A. Prince, 2002, Antimicrobial Agents and Chemotherapy.

KPC-Producing Klebsiella pneumoniae Rifampin against Colistin-Resistant Synergistic Activity of Colistin plus

Russell E. Lewis, B. Casini, G. Rossolini, 2014 .

Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae

Russell E. Lewis, B. Casini, G. Rossolini, 2013, Antimicrobial Agents and Chemotherapy.

The Impact of Antifungal Drug Resistance in the Clinic

Russell E. Lewis, D. Kontoyiannis, R. Lewis, 2012 .

Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections

Russell E. Lewis, R. Lewis, 2012, American journal of therapeutics.

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007)

Russell E. Lewis, D. Kontoyiannis, J. Tarrand, 2009, Cancer.

Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.

Russell E. Lewis, D. Kontoyiannis, N. Sipsas, 2009, International journal of antimicrobial agents.

Overview of the changing epidemiology of candidemia.

Russell E. Lewis, R. Lewis, 2009, Current medical research and opinion.

Assessment of Antifungal Activities of Fluconazole and Amphotericin B Administered Alone and in Combination againstCandida albicans by Using a Dynamic In Vitro Mycotic Infection Model

Russell E. Lewis, Erika J. Ernst, Michael E. Klepser, 1998, Antimicrobial Agents and Chemotherapy.

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida

Russell E. Lewis, D. Kontoyiannis, Dimitrios P. Kontoyiannis, 2012, Virulence.

Immunomodulating effects of antifungal therapy

Russell E. Lewis, D. Kontoyiannis, R. Ben-Ami, 2009 .

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.

Russell E. Lewis, D. Kontoyiannis, T. Walsh, 2008, The Journal of infectious diseases.

Immunocompromised hosts: immunopharmacology of modern antifungals.

Russell E. Lewis, D. Kontoyiannis, R. Ben-Ami, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

Russell E. Lewis, D. Kontoyiannis, G. Chamilos, 2007, Antimicrobial Agents and Chemotherapy.

Echinocandins – Caspofungin, Anidulafungin and Micafungin

Russell E. Lewis, D. Kontoyiannis, R. Lewis, 2010 .

Antifungal Drug Interactions

Russell E. Lewis, R. Lewis, 2009 .

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

Russell E. Lewis, D. Kontoyiannis, J. Tarrand, 2012, The Journal of infection.

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature

Russell E. Lewis, S. Paolini, F. Bonifazi, 2019, Mycoses.

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Russell E. Lewis, H. Kantarjian, D. Kontoyiannis, 2005, The Journal of infectious diseases.

Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.

Russell E. Lewis, D. Kontoyiannis, I. Raad, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models.

Russell E. Lewis, A. Mitchell, D. Kontoyiannis, 2009, The Journal of infectious diseases.

Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.

Russell E. Lewis, G. Halder, D. Kontoyiannis, 2005, The Journal of infectious diseases.

Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole

Russell E. Lewis, D. Kontoyiannis, G. Chamilos, 2006, Antimicrobial Agents and Chemotherapy.

A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies

Russell E. Lewis, M. Baccarani, N. Vianelli, 2013, PloS one.

Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?

Russell E. Lewis, D. Kontoyiannis, P. Strati, 2021, The Lancet. Haematology.

Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.

Russell E. Lewis, D. Kontoyiannis, R. Ben-Ami, 2013, The Journal of infectious diseases.

Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.

Russell E. Lewis, D. Kontoyiannis, R. Ben-Ami, 2009, Blood.

Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways

Russell E. Lewis, D. Kontoyiannis, N. Wiederhold, 2005, Antimicrobial Agents and Chemotherapy.

Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species

Russell E. Lewis, D. Kontoyiannis, Marisa Z. R. Gomes, 2011, Clinical Microbiology Reviews.

Evaluation of antifungals in the surgical intensive care unit: a multi‐institutional study

Russell E. Lewis, L. Gentry, K. Garey, 2006, Mycoses.

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high‐risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

Russell E. Lewis, Xin Han, Jorge Cortes, 2007, Cancer.

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease

Russell E. Lewis, M. Stanzani, R. Lewis, 2018, Journal of fungi.

Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges

Russell E. Lewis, D. Kontoyiannis, R. Ben-Ami, 2009, Current opinion in infectious diseases.

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Russell E. Lewis, T. Calandra, M. Bassetti, 2020, Intensive Care Medicine.

Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti‐tubercular treatment

Russell E. Lewis, A. Pinna, M. Tadolini, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Oral Gentamicin Gut Decontamination for Prevention of KPC-Producing Klebsiella pneumoniae Infections: Relevance of Concomitant Systemic Antibiotic Therapy

Russell E. Lewis, G. Rossolini, C. Tascini, 2014, Antimicrobial Agents and Chemotherapy.

Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment.

Russell E. Lewis, C. Arias, D. Kontoyiannis, 2013, Microbial pathogenesis.

Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.

Russell E. Lewis, J. Sinko, N. Skoetz, 2022, The Lancet. Haematology.

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Russell E. Lewis, D. D. de Lange, T. Calandra, 2021, Intensive Care Medicine.

Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options

Russell E. Lewis, J. Bewersdorf, A. Zeidan, 2021, Cancer management and research.